Showing results (421-430 of 752) with videos related to

Sort By:
Pageof 76
Behavior Therapy|April 23, 2023
Developing Transdiagnostic Internalizing Disorder Prognostic Indices for Outpatient Cognitive Behavioral TherapyAnthony J Rosellini, Alexandra M Andrea, Christina S Galiano, et al.
ACS Chemical Biology|October 28, 2020
Fluorescent dATP for DNA Synthesis In VivoVerena N Schreier, Morten O Loehr, Ting Deng, et al.
American Journal of Epidemiology|April 20, 2021
Invited Commentary: New Directions in Machine Learning Analyses of Administrative Data to Prevent Suicide-Related BehaviorsRobert M Bossarte, Chris J Kennedy, Alex Luedtke, et al.
Clinical Interventions in Aging|August 1, 2013
Effects and feasibility of an Integrative Medicine program for geriatric patients-a cluster-randomized pilot studyMichael Teut, Katharina Schnabel, Roland Baur, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 31, 2015
Multiple excitatory and inhibitory neural signals converge to fine-tune Caenorhabditis elegans feeding to food availabilityNicolas Dallière, Nikhil Bhatla, Zara Luedtke, et al.
Pharmacology, Biochemistry, and Behavior|May 29, 2018
Dopamine D3 receptor partial agonist LS-3-134 attenuates cocaine-motivated behaviorsGregory L Powell, John Paul Bonadonna, Annika Vannan, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 4, 2011
Influence of cocaine history on the behavioral effects of Dopamine D(3) receptor-selective compounds in monkeysB L Blaylock, R W Gould, A Banala, et al.
Scandinavian Journal of Gastroenterology|May 17, 2007
Effects of a comprehensive lifestyle modification program on quality-of-life in patients with ulcerative colitis: a twelve-month follow-upJost Langhorst, Twyla Mueller, Rainer Luedtke, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 21, 2010
Decreased striatal dopamine receptor binding in primary focal dystonia: a D2 or D3 defect?Morvarid Karimi, Stephen M Moerlein, Tom O Videen, et al.
Journal of Clinical Pharmacology|November 7, 2017
Pharmacokinetics of Nintedanib in Subjects With Hepatic ImpairmentKristell Marzin, Gunther Kretschmar, Doreen Luedtke, et al.
Pageof 76